Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30-year-old mystery

American Journal of Medical Genetics, Part A

Volumn 152, Issue 6, 2010, Pages 1531-1535

  Schimke, R Neil ^a   Collins, Debra L ^a   Stolle, Catherine A ^b  

^a UNIVERSITY OF KANSAS   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Neuroblastoma; Paraganglioma; Pheochromocytoma; Renal cell carcinoma; SDHB mutations

Indexed keywords

DNA;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; GENE; GENE MUTATION; HUMAN; KIDNEY CARCINOMA; MALE; NEUROBLASTOMA; PARAGANGLIOMA; PEDIGREE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SDHB GENE;

ADULT; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASMS, SECOND PRIMARY; NEUROBLASTOMA; PARAGANGLIOMA; SUCCINATE DEHYDROGENASE; YOUNG ADULT;

EID: 77952779769     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33384     Document Type: Article

References (46)

1. Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Rogueplo A-P, Plovin P-F. 2007. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 92:3822-3828.
2. Armstrong R, Greenhalgh KL, Rattenberry R, Judd B, Shukla R, Losty PD, Maher ER. 2009. Succinic dehydrogenase subunit B gene deletion associated with a composite paraganglioma/neuroblastoma. J Med Genet 46:215-216.
3. Astuti D, Morris M, Krona C, Abel F, Gentle D, Martinsson T, Kogner P, Neumann HP, Voutilainen R, Eng C, Rustin P, Latif F, Maher ER. 2004. Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma. Br J Cancer 91:1835-1841. (Pubitemid 39664973)
4. Bassal M, Mertens AC, Taylor L, Neglia JP, Graffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadam-Lottick NS. 2006. Risk of selected subsequent carcinomas in survivors of childhood cancer, a report from the childhood cancer survivor study. J Clin Oncol 24:476-483. (Pubitemid 46630467)
5. Baysal BE. 2008. Clinical and molecular progress in hereditary paraganglioma. J Med Genet 45:689-694.
6. Baysal BE, Ferrell RE, Willett-Broziak JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard CW III, Cornelisse CJ, Devilee P, Devlin B. 2000. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:843-851. (Pubitemid 30084326)
7. Baysal BE, Willet-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, Yee HA, Brachmann DE, Slattery WH III, Meyers EN, Ferrell RE, Robinson WS. 2002. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 39:178-183.
8. Benn DE, Croxson MS, Tucker K, Bambach CP, Richardson AL, Delbridge L, Pullan PT, Hammond J, Marsh DJ, Robinson BG. 2003. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial pheochromocytomas and paragangliomas, but an absence of somatic SHDB mutations in sporadic pheochromocytomas. Oncogene 22:1358-1364. (Pubitemid 36384597)
9. Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, Pacak K. 2006. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: Implications for genetic testing. J Clin Endocrinol Metab 91:4505-4509. (Pubitemid 44833431)
10. Cascón A, Landa Í, López-Jiménez E, Diez-Hernández A, Buchta M, Montero-Conde C, Leskelä S, Leandro-Garcia LJ, Letón R, Rodriguez- Antona C, Eng C, Neumann HPH, Robledo M. 2008. Molecular characterisation of a common SDHB deletion in paraganglioma patients. J Med Genet 45:233-238. (Pubitemid 351518729)
11. Chen Y, Takita J, Choi YL, Kato M, Ohira M, Samada M, Wang L, Soda M, Kikuchi A, Igaraski T, Nakagawara A, Hayashi Y, Mano H, Ogawa S. 2008. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455:971-974.
12. Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, Cole K, Mossé YP, Wood A, Lynch JE, Pecor K, Diamond M, Winter C, Wang K, Kim C, Geiger EA, McGrady PW, Blakemore AIF, London WB, Shaikh TH, Bradfield J, Grant SFA, Hongzhe L, Devoto M, Rappaport ER, Hakmarson H, Maris JH. 2009. Copy number variation at 1q21.1 associated with neuroblastoma. Nature 459:987-991.
13. Elston MS, Benn D, Robinson BG, Conaglen JV. 2006. An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years. Int Med J 36:129-131. (Pubitemid 43287325)
14. Eng C. 2008. A ringleader identified. Nature 455:883-884.
15. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. 2003. A role for mitochondrial mutations in inherited neoplasia and beyond. Nat Rev Cancer 3:193-202. (Pubitemid 37328871)
16. Fairchild RS, Kyner JL, Hermrech A, Schimke RN. 1979. Neuroblastoma, pheochromocytoma, and renal cell carcinoma. Occurrences in a single patient. JAMA 242:2210-2211.
17. Fleitz JM, Wooten-Gorges SL, Wyatt-Ashead J, McGavran L, Koyle M, West DC, Kurzrock EA, Martin KW, Odom LF. 2003. Renal cell carcinoma in long term survivors of advanced stage neuroblastoma in early childhood. Pediat Radiol 33:540-545. (Pubitemid 36975067)
18. Grau E, Oltra S, Orellana C, Hernandez-Marti M, Castel V, Martinez F. 2005. There is no evidence that the SDHB gene is involved in neuroblastoma development. Oncol Res 15:393-398. (Pubitemid 43198596)
19. Henderson A, Douglas F, Perros P, Morgan C, Maher ER. 2009. SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis. Fam Cancer 8:257-260.
20. Klein RD, Lloyd RV, Young WF. 2008. (Updated 21 May 2008). Hereditary paraganglioma-pheochromocytoma syndromes. In: GeneReviews at GeneTests: Medical Genetics Information Resources (database online). Copyright, University of Washington, Seattle. 1997-2009. Available at http://www.genetests.org. Accessed [2/2/09].
21. Koyle MA, Hatch DA, Furness PD III, Lovel MA, Odom LF, Kurzrock EA. 2001. Long-term urological complications in survivors younger than 15 months of advanced stage abdominal neuroblastoma. J Urol 166: 1455-1458.
22. Ladroue G, Carcenac R, Leporrier J, Gad S, Lettello C, Galateau-Salle F, Feimteun J, Pouysségur J, Richard S, Gardie B. 2008. PHD2 mutation and congenital erythrocytosis with paraganglioma. N Eng J Med 359: 2685-2692.
23. Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan M-P, Farese RV, Freeman RS, Carter BD, Kaelin WG Jr, Schlesio S. 2005. Neuronal apoptosis linked to EgIN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer. Cancer Cell 8:155-167. (Pubitemid 41132744)
24. Lopez-Andrew JA, Castel V, Verdequer A, Muro MD, Esquembre C, Ferris J. 1995. Neuroblastma IV-5 followed by extra-adrenal pheochromocytoma 15 years later. Med Pediat Oncol 24:388-391.
25. Malek R, McCarthy-Keith D, Levens ED, Merino MJ, DeCherney AH, Weinstein LS. 2008. A gastrointestinal stromal tumor in a patient with multiple endocrine neoplasia type 2A and metastatic medullary thyroid cancer to the ovaries. Endo Pract 14:898-901.
26. Matias-Guiu X, Garrastazu MI. 1998. Composite phaeochromocytoma with ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIA. Histopathology 32:281-282.
27. McWhinney SR, Pilarski RT, Forrester SR, Schneider MC, Sarquis MM, Dias EP, Eng C. 2004. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J Clin Endocrinol Metab 89:5694-5699. (Pubitemid 39518460)
28. McWhinney SR, Pasini B, Stratakis CA. 2007. Familial gastrointestinal stromal tumors and germline mutations. N Eng J Med 357:1054-1056. (Pubitemid 47367102)
29. Medeiros L, Jeffrey MD, Palmedo G, Krigman HR, Kovacs G, Beckwith JB. 1999. Oncocytoid renal cell carcinoma after neuroblastoma: A report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol 23: 772-780. (Pubitemid 29307682)
30. Nakagawara A, Neda K, Tsuneyoshi M, Daimaru Y, Enjoji M. 1985. Malignant pheochromocytoma with ganglioneuroblastoma elements in a patient with von Recklinghausen's disease. Cancer 55:2794-2798. (Pubitemid 15008317)
31. Neumann HP, Eng C. 2009. The approach to the patient with paraganglioma. J Clin Endocrinol Metab 94:2677-2683.
32. Neumann HP, Pawlin C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C. 2004. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943-951. (Pubitemid 39097204)
33. Ni Y, Zbuk KM, Sadler T, Patocs A, Lobo G, Edelman E, Platzer P, Orloff MS, Waite KA, Eng C. 2008. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet 83:261-268.
34. Ricketts C, Woodward ER, Killick P, Morris M, Astute D, Latif F, Maher ER. 2008. Germline SDHB mutations and familial renal cell carcinoma. J Med Genet 45:SP25.
35. Rubin BP. 2006. Gastrointestinal stromal tumors: An update. Histopathology 48:83-96.
36. Rubino C, Adjadj E, Guérin S, Guibout C, Shamsaldin A, Dondon MG, Valteau-Couanet D, Hartmann O, Hawkins M, deVathaire F. 2003. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: Role of treatment. Int J Cancer 107:791-796.
37. Schimke RN, Collins DC. In press. von Hippel-Lindau Syndrome. In: Cassidy SB, Allanson JE, editors. Management of Genetic Syndromes. 3rd edition. Wiley-Blackwell. p 881-895.
38. Schlisio S, Kenchappa RS, Vredeveld LCW, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, Pomeroy SL, Maris JM, Look AT, Meyerson M, Peeper DS, Carter BD, Kaelin WE Jr. 2008. The kinesin KIFIBβ acts downstream from EgIN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Devel 22:884-893. (Pubitemid 351482842)
39. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mans-field KD, Pan Y, Simion MC, Thompson CB, Gottlieb E. 2005. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7:77-85. (Pubitemid 40126384)
40. Shlein A, Tabori U, Marshall CR, Pienkowska M, Feuk L, Novokmet A, Nanda S, Druker H, Scherer SW, Malkin D. 2008. Excessive genomic DNA copy number variations in the Li-Fraumeni cancer predisposition syndrome. Proc Nat Acad Sci 105:11264-11269.
41. Shojaei-Brosseau T, Compret A, Abel A, deVathaire F, Raquin MA, Brugieres L, Feunteun J, Hartmann O, Bonaïti-Pellié C. 2004. Genetic epidemiology of neuroblastoma: A study of 426 cases at the Institut Gustave-Roussy in France. Pediatr Blood Cancer 42:99-105.
42. Tatekawa Y, Muraji T, Nishijima E, Yoshida M, Tsugawa C. 2006. Composite pheochromocytoma associated with neuroblastoma in an infant:A case report. J Pediatr Surg 41:443-445. (Pubitemid 43233870)
43. Timmers HJLM, Pacak K, Huynk TT, Abu-Asab M, Tsokos M, Merino MJ, Baysal BE, Adams KT, Eisenhofer G. 2008. Biochemically silent paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene. J Clin Endocrinol Metab 93:4826-4832.
44. Trochet D, Bourdeaut F, Janoueix-Lerosey I, Deville A, dePontual L, Schleiermacher G, Coze C, Philip N, Frébourg T, Munnich A, Lyonnet S, Delattre D, Armiel J. 2004. Germline mutations in the paired-like homeobox 2β (PHOX2B) gene in neuroblastoma. Am J Hum Genet 74:761-764.
45. Vanharanta S, Buchta M, McWhinnery SR, Virta SK, Peczkowska M, Morrison CD, Lehtonen R, Januszewicz A, Jarvinen H, Juhola M, Mecklin JP, Pukkala E, Herva R, Kiuru M, Nupponen NN, Aaltonen LA, Neumann HP, Eng C. 2004. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 74:153-154.
46. Young AL, Baysal BE, Deb A, Young WF Jr. 2002. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. J Clin Endocrinol Metab 87:4101-4105.